Immunohistochemical analysis of primary liver cancer
https://doi.org/10.18027/2224-5057-2016-3-44-53
Abstract
The paper presents the basic principles of performing immunohistochemical study biopsies in patients with focal lesions of the liver. The results of a comprehensive study of its own morphology and histogenesis of primary malignant liver tumors. The study immunogenotipa liver tumors has enabled us not only to clarify the histogenesis of the tumor, differential diagnosis of primary and metastatic tumors, but also in a number of observations to establish the localization of the primary tumor, which ensured the implementation of adequate surgery and determine the tactics of therapy.
About the Authors
R. V. ISCHENKO
Moscow Regional Oncological Center
Russian Federation
Russian Federation
MD, PhD, DSc, head of the Oncology Department 11
M. A. ANDREEVA
Moscow Regional Oncological Center
Russian Federation
Russian Federation
head of the Pathology Department
E. V. YAKOVLEVA
Moscow Regional Oncological Center
Russian Federation
Russian Federation
physician pathology department
K. B. ISHCHENKO
Moscow Regional Oncological Center
Russian Federation
physician pathology department
Russian Federation
physician pathology department
References
1. Хазанов А. И. Гепатоцеллюлярная карцинома. В кн.: Гастроэнтерология и гепатология. М., 2011; с. 759–766. A. I. Khazanov Hepatocellular carcinoma. Proc .: Gastroenterology and Hepatology. M., 2011; from. 759,766.
2. Маев И. В., Дичева Д. Т., Жиляев Е. В. и др. Трудности диагностики гепатоцеллюлярной карциномы Consilium Med. 2010; 8: 63 66. Maiev I. V., Dichev D. T., Jiliaev E. V. and others. The difficulty of diagnosis of hepatocellular carcinoma Consilium Med. 2010; 8: 63 66.
3. Пышкин С. А. Пирогова И. Ю. Гепатоцеллюлярная карцинома: алгоритм диагностики, возможности лечения. Клин. перспективы гастроэнтерологии, гепатологии. 2010; 5: 17 23. Pyshkin S. A. Pirogov I. Y. Hepatocellular carcinoma: diagnostic algoritm, treatment options. Wedge. prospects of gastroenterology, hepatology. 2010; 5: 17, 23.
4. Ивашкин В. Т., Морозова М. А., Маевская М. В. и др. Факторы риска развития гепатоцеллюлярной карциномы. Рос. журнал гастроэнтерол., гепатол., колопроктол. 2009; т. 19, № 1: 4.15. Ivashkin V. T., M. A. Morozova, M. V. Maevskaya et al. Risk factors for hepatocellular carcinoma. Ros. Journal gastroenterol gepatol to loproktol. 2009; t 19, № 1:. April 15.
5. Шапошников А. В., Простакова Н. А. Сравнительная частота различных факторов риска первичных злокачественных поражений печени. Рос. журнал гастроэнтерол., гепатол., колопроктол. 2004; т. 14, № 3: 60 65. Shaposhnikov A. V., Prost N. A. Comparatively frequency of various risk factors governmental primary malignant liver lesions. Ros. Journal gastroenterology gepatolgy koloproktology. 2004; t 14, № 3:. 60 65.
6. Кучерявый Ю. А., Оганесян Т. С., Стукова Н. Ю. Гепатоцеллюлярная карцинома: взгляд врача общей практики. Consilium Med. 2011; 1: 38 45. Kucherjavyj Y. A., Hovhannisyan T. S., Stukova N. Y. Hepatocellular carcinoma: a view of a general practitioner. Consilium Med. in 2011; 1: 38 45.
7. Вольфганг Герок, Хуберт Е. Блюм. Заболевания печени и желчевыделительной системы. М., 2009; с. 167–170. Gerok W. Blum H. E. Diseases of the liver and bile excretory system. M., 2009; from. 167,170.
8. Комаров Ф. И., Гребенев А. Л. Руководство по гастроэнтерологии. М., 1992; т. 2. Komarov F.I., Grebenev A.L. Manual of Gastroenterology. M., 1992; V.2.
9. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. М., 2002. Sherlock S., Dooley J. Of the liver and biliary tract diseases. Moscow, 2002.
10. МакНелли П. Р. Секреты гастроэнтерологии. М., 2005. McNally P.R. Secrets of Gastroenterology. Moscow, 2005.
11. Llovet J. M., Fuster J., Bruik J. The Barcelona Approach: diagnosis, staging, and treatment of hepato cellular carcinoma. Liver Transplant. 2004; 10: 115 120.
12. Van Nieuwkerk C. M., Rauws E. A., Tytgat G. N. et al. Diagnosis and treatment of hepatocellular carci noma: new approaches. New Tijdschr Geneeskd. 1996; 140(17): 922 6.
13. Калинин А. В., Логинов А. Ф., Хазанов А. И. Гастроэнтерология и гепатология: диагностика и лечение. М., 2011. Kalinin A. V., Loginov A. F., Hazanov A. I. Gastrojenterologija i gepatologija: diagnostika i lechenie. M., 2011.
14. Мухин Н. А. Практическая гепатология. М.,2004. Muhin N. A. Prakticheskaja gepatologija. M.,2004.
15. Sherlock Sh. Diseases of the Liver and Biliary System. Oxford, 1975.
16. Biselli M., Gramezi A., Cursaro C. et al. Transcatheter arterial chemoembolization therapy {TACE} for patients with hepatocellular carcinoma {HCC}: a comparative study using a matched untreat ment cohort. Abstracts 37th Annual Meeting EASL. 2002. April 18 21. Madrid. Abstr. 761.
17. Livraghi T., Bolondi L., Lazzaroni S. et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinomain cirrhosis. A study on 207 patients. Cancer, 1992; 69: 925 9.18. Малиновская Ю. О., Лопаткина Т. Н., Одинцов А. В. Современные методы лечения гепатоцеллюлярной карциномы у больного вирусным {HBV} циррозом печени. Клин Гепатол. 2010; 4: 41 43. Malinovskaja Ju. O., Lopatkina T. N., Odincov A. V. Sovremennye metody lechenija gepatocelljuljarnoj karcinomy u bol’nogo virusnym {HBV} cirrozom pecheni. Klin Gepatol. 2010; 4: 41 43.
18. Fattovich G., Bortolotti E., Donato F. Natural history of chronic hepatitis B: special emphasis on dis ease progression and prognostic factors. J Hepatol. 2008; 48: 335 52.
19. Raza S. A., Clifford G. M., Franceschi S. World wide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatoctllular carcinoma: a systematic review. British J Cancer. 2007; 96: 1127 34.
20. Chen C. J., Yang H., Su J. et al. Risk of hepato cellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006; 295: 65 73.
21. Iloeje U., Yang H., Su J. et al. Viral load is a strong predictor of hepatocellular carcinoma risk in people chron ically infected with hepatitis B virus and normal serum alanine aminotransferase level. J Hepatol. 2005; 42: 179.
22. Mazzaferro V., Regalia E., Doci R. et al. Liver transplantation for the treatment of small hepatocellu lar carcinomas in patients with cirrhosis. N Engl J Med. 1996; 14: 728 95.
23. O’ Grady J. G., Poison R. J., Rolles K. et al. Liver transplantation for malignant disease: results in 93 consecutive patients. Ann Surg. 1988; 207: 373 9.
24. Ivatsuki S., Starzl T. E., Sheahan D. C. et al. Hepatic resection versus transplantation. 1991; 214: 221 9.
25. Bismuth H., Chiche L., Adam R. et al. Liver resec tion versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Sur. 1993; 218: 145 51.
Review
For citations:
ISCHENKO R.V., ANDREEVA M.A., YAKOVLEVA E.V., ISHCHENKO K.B. Immunohistochemical analysis of primary liver cancer. Malignant tumours. 2016;(3):44-53. (In Russ.) https://doi.org/10.18027/2224-5057-2016-3-44-53
Views:
1565
Email this article 